CAS RN: 63592-85-8
Methyl 4-Chloronicotinate
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250703
5g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 63592-85-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
63592-85-8 / methyl 4-chloropyridine-3-carboxylate
Standard CAS: 63592-85-8
Multi CAS: Yes
Basic Information
copy
CAS
63592-85-8 copy
Multi CAS
Yes copy
Molecular Formula
C7H6CLNO2 copy
Molecular Weight
171.580000 copy
Exact Mass
171.008706 copy
InChI
InChI=1S/C7H6ClNO2/c1-11-7(10)5-4-9-3-2-6(5)8/h2-4H,1H3 copy
InChIKey
SNZRPPBWRSEVIU-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.14 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
Molar refractivity
40.59 copy
TPSA
39.19 copy
LogP / Solubility
WLOGP
1.52 copy
MLOGP
1.34 copy
XLogP3
1.3 copy
Consensus LogP
1.39 copy
Log S (ESOL)
-2.2 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.07 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.16 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.69 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy